SAB BIOTHERAPEUTICS INC (SABS) Institutional Ownership
None of the superinvestors we track currently report SAB BIOTHERAPEUTICS INC (SABS) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in SAB BIOTHERAPEUTICS INC (SABS), this page will show institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2025 | 1 | $162,488 | 80,840 |
| Q2 2025 | 1 | $19,358 | 11,030 |
| Q1 2025 | 1 | $13,641 | 10,030 |
Related SABS Institutional Insights:
- SABS Institutional Ownership & Insiders Activity
- SABS Institutional Ownership & 13F Activity
- SABS Top Institutional Shareholders
- SABS Institutional Buying Activity
- SABS Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- SABS Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings